Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT01777191 · COMPLETED
Trial details
- NCT number
- NCT01777191
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-05-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.